
    
      A prospective clinical sample collection and cardiac troponin I testing will be conducted in
      individuals presenting to the Emergency Department (ED) with signs and/or symptoms suggestive
      of acute coronary syndrome (ACS) at geographically dispersed sites in the US. Individuals who
      meet the inclusion/exclusion criteria, including having signed an informed consent form will
      be included in the study.

      Clinical and laboratory data will be collected to demonstrate product performance compared to
      an adjudicated clinical diagnosis.

      Sample collection and testing of clinical samples with the VITROS hs Troponin I test will be
      performed under two separate protocols.
    
  